EcoDrugPlus

Glutamate Receptor 1-Like

Ensembl ID : ENSSFOG00015016777
Gene Symbol: LOC108936848
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSFOG00015022558
Gene Symbol: LOC108934427
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSFOG00015014898
Gene Symbol: LOC108924471
3 Cross references
241 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSSFOG00015020773
Gene Symbol: LOC108921470
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSSFOG00015011665
Gene Symbol: LOC108938618
3 Cross references
151 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSSFOG00015013108
Gene Symbol: LOC108922658
3 Cross references
206 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSSFOG00015010742
Gene Symbol: GRIN2BB
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSSFOG00015011637
Gene Symbol: GRM5A
1 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSSFOG00015016586
Gene Symbol: GRM5B
1 Cross references
149 Possible Orthologues:

Glutaminase

Ensembl ID : ENSSFOG00015017398
Gene Symbol: GLS
3 Cross references
301 Possible Orthologues:

Glutaminase

Ensembl ID : ENSSFOG00015007335
Gene Symbol: GLS
3 Cross references
302 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSSFOG00015003969
Gene Symbol: GSTP1
3 Cross references
143 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).